INTRODUCTION: Long QT Syndrome (LQTS) is an inherited disorder characterized by prolonged QT intervals and life-threatening polymorphic ventricular tachyarrhythmias. LQT1 caused by KCNQ1 mutations is the most common form of LQTS. METHODS AND RESULTS: Patients diagnosed with LQTS were screened for disease-associated mutations in KCNQ1, KCNH2, KCNE1, KCNE2, KCNJ2, and SCN5A. A novel mutation was identified in KCNQ1 caused by a three-base deletion at the position 824-826, predicting a deletion of phenylalanine at codon 275 in segment 5 of KCNQ1 (DeltaF275). Wild-type (WT) and DeltaF275-KCNQ1 constructs were generated and transiently transfected together with a KCNE1 construct in CHO-K1 cells to characterize the properties of the slowly activating delayed rectifier current (IKs) using conventional whole-cell patch-clamp techniques. Cells transfected with WT-KCNQ1 and KCNE1 (1:1.3 molar ratio) produced slowly activating outward current with the characteristics of IKs. Tail current density measured at -40 mV following a two-second step to +60 mV was 381.3 +/- 62.6 pA/pF (n = 11). Cells transfected with DeltaF275-KCNQ1 and KCNE1 exhibited essentially no current. (Tail current density: 0.8 +/- 2.1 pA/pF, n = 11, P = 0.00001 vs WT). Cotransfection of WT- and DeltaF275- KCNQ1 (50/50), along with KCNE1, produced little to no current (tail current density: 10.3 +/- 3.5 pA/pF, n = 11, P = 0.00001 vs WT alone), suggesting a potent dominant negative effect. Immunohistochemistry showed normal membrane trafficking of DeltaF275-KCNQ1. CONCLUSION: Our data suggest that a DeltaF275 mutation in KCNQ1 is associated with a very potent dominant negative effect leading to an almost complete loss of function of IKs and that this defect underlies a LQT1 form of LQTS.
INTRODUCTION:Long QT Syndrome (LQTS) is an inherited disorder characterized by prolonged QT intervals and life-threatening polymorphic ventricular tachyarrhythmias. LQT1 caused by KCNQ1 mutations is the most common form of LQTS. METHODS AND RESULTS:Patients diagnosed with LQTS were screened for disease-associated mutations in KCNQ1, KCNH2, KCNE1, KCNE2, KCNJ2, and SCN5A. A novel mutation was identified in KCNQ1 caused by a three-base deletion at the position 824-826, predicting a deletion of phenylalanine at codon 275 in segment 5 of KCNQ1 (DeltaF275). Wild-type (WT) and DeltaF275-KCNQ1 constructs were generated and transiently transfected together with a KCNE1 construct in CHO-K1 cells to characterize the properties of the slowly activating delayed rectifier current (IKs) using conventional whole-cell patch-clamp techniques. Cells transfected with WT-KCNQ1 and KCNE1 (1:1.3 molar ratio) produced slowly activating outward current with the characteristics of IKs. Tail current density measured at -40 mV following a two-second step to +60 mV was 381.3 +/- 62.6 pA/pF (n = 11). Cells transfected with DeltaF275-KCNQ1 and KCNE1 exhibited essentially no current. (Tail current density: 0.8 +/- 2.1 pA/pF, n = 11, P = 0.00001 vs WT). Cotransfection of WT- and DeltaF275- KCNQ1 (50/50), along with KCNE1, produced little to no current (tail current density: 10.3 +/- 3.5 pA/pF, n = 11, P = 0.00001 vs WT alone), suggesting a potent dominant negative effect. Immunohistochemistry showed normal membrane trafficking of DeltaF275-KCNQ1. CONCLUSION: Our data suggest that a DeltaF275 mutation in KCNQ1 is associated with a very potent dominant negative effect leading to an almost complete loss of function of IKs and that this defect underlies a LQT1 form of LQTS.
Authors: F Y Shalaby; P C Levesque; W P Yang; W A Little; M L Conder; T Jenkins-West; M A Blanar Journal: Circulation Date: 1997-09-16 Impact factor: 29.690
Authors: L Zhang; K W Timothy; G M Vincent; M H Lehmann; J Fox; L C Giuli; J Shen; I Splawski; S G Priori; S J Compton; F Yanowitz; J Benhorin; A J Moss; P J Schwartz; J L Robinson; Q Wang; W Zareba; M T Keating; J A Towbin; C Napolitano; A Medina Journal: Circulation Date: 2000-12-05 Impact factor: 29.690
Authors: F Yamashita; M Horie; T Kubota; H Yoshida; Y Yumoto; A Kobori; T Ninomiya; Y Kono; T Haruna; K Tsuji; T Washizuka; M Takano; H Otani; S Sasayama; Y Aizawa Journal: J Mol Cell Cardiol Date: 2001-02 Impact factor: 5.000
Authors: E Schulze-Bahr; W Haverkamp; H Wiebusch; H Schulte; M Hördt; M Borggrefe; G Breithardt; G Assmann; H Funke Journal: J Mol Med (Berl) Date: 1995-11 Impact factor: 4.599
Authors: A J Moss; W Zareba; J Benhorin; E H Locati; W J Hall; J L Robinson; P J Schwartz; J A Towbin; G M Vincent; M H Lehmann Journal: Circulation Date: 1995-11-15 Impact factor: 29.690
Authors: Elon C Roti Roti; Cena D Myers; Rebecca A Ayers; Dorothy E Boatman; Samantha A Delfosse; Edward K L Chan; Michael J Ackerman; Craig T January; Gail A Robertson Journal: J Biol Chem Date: 2002-09-20 Impact factor: 5.157
Authors: Ikuomi Mikuni; Carlos G Torres; Tania Bakshi; Akihito Tampo; Brian E Carlson; Martin W Bienengraeber; Wai-Meng Kwok Journal: Anesthesiology Date: 2015-04 Impact factor: 7.892
Authors: Jonathan M Cordeiro; Guillermo J Perez; Nicole Schmitt; Ryan Pfeiffer; Vladislav V Nesterenko; Elena Burashnikov; Christian Veltmann; Martin Borggrefe; Christian Wolpert; Rainer Schimpf; Charles Antzelevitch Journal: Can J Physiol Pharmacol Date: 2010-12 Impact factor: 2.273